Laboratory service provider Labcorp said on Wednesday it will acquire Softbank-backed Invitae Corp's assets auctioned through a voluntary bankruptcy protection process, a few months after the genetic
Softbank-backed genetic test maker Invitae said on Tuesday it has filed for voluntary Chapter 11 protection in a U.S. bankruptcy court and intends to pursue a sale process.
Invitae (NYSE: NVTA ) stock fell as much as 78% yesterday before it was ultimately halted because undisclosed news about the firm was pending. Many investors now expect that the SoftBank (OTCMKTS: SFT

Why Is Invitae (NVTA) Stock Down 75% Today?

02:26pm, Monday, 05'th Feb 2024
Medical genetics firm Invitae (NYSE: NVTA ) suffered a shocking fall from grace as insider reports point to an upcoming bankruptcy filing. Although the company forwarded a compelling concept — lever
Medical test maker Invitae is preparing to file for bankruptcy within weeks, the Wall Street Journal reported on Monday, according to people familiar with the matter.

Is Invitae Stock a Buy Now?

04:46am, Monday, 29'th Jan 2024
Invitae has made progress in its business realignment plan, cutting cash burn by one-half from 2022 to 2023. However, the company still faces significant challenges.
We have crafted a tree with the most flourishing stocks of 2023 and the ones that are poised to soar in 2024.
Invitae (NVTA) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that ma

Why Are Chinese Stocks Up Today?

11:35am, Friday, 15'th Dec 2023
Chinese stocks are up today and investors wondering why can find out all about these movements with our coverage for Friday! All of this comes from recent data concerning the Chinese economy.

What Makes Invitae (NVTA) a New Buy Stock

01:32pm, Wednesday, 13'th Dec 2023
Invitae (NVTA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
The allure of Cathie Wood Stocks investing prowess has captured a large audience of investors. Yet, even amidst all of the optimism surrounding her investment strategies, prudent investors must be awa
CRISPR Therapeutics may soon generate its first product revenue. Invitae, making progress in its recovery plan, could climb if it meets its goals.
Invitae Corporation (NYSE:NVTA ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Hoki Luk - VP, IR and Corporate Development Ken Knight - President & CEO Ana Schrank
The headline numbers for Invitae (NVTA) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street esti

3 Things About Invitae Every Smart Investor Knows

09:59am, Saturday, 04'th Nov 2023
Invitae's stock is down and it might get delisted from its stock exchange. It has a new crop of top managers, but it's running low on cash.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE